Allergan, a division of the American biopharmaceutical company Abbvie, announced at the end of February that it has filed a new drug application with the U.S. Food and Drug Administration (FDA) for eye drops aimed at treating presbyopia. The ophthalmic solution has already been tested successfully with 750 patients, resulting ...
Buying a membership today will give you:
To continue reading this article register now.